Search

Search results

192 results found

Real-world compliance with the 2020 U.S. Multi-Society Task Force on Colorectal Cancer polypectomy surveillance guidelines: an observational study.

Publication: Journal Article

Dong, Jeffrey, Linda F Wang, Eric Ardolino, and Joseph D Feuerstein. 2023. “Real-World Compliance With the 2020 U.S. Multi-Society Task Force on Colorectal Cancer Polypectomy Surveillance Guidelines: An Observational Study.”. Gastrointestinal Endoscopy 97 (2): 350-356.e3.

Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases.

Publication: Journal Article

Papamichael, Konstantinos, Adam S Cheifetz, Gil Y Melmed, Peter M Irving, Niels Vande Casteele, Patricia L Kozuch, Laura E Raffals, et al. 2019. “Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases.”. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 17 (9): 1655-1668.e3.

Higher Postinduction Infliximab Concentrations Are Associated With Improved Clinical Outcomes in Fistulizing Crohn's Disease: An ACCENT-II Post Hoc Analysis.

Publication: Journal Article

Papamichael, Konstantinos, Niels Vande Casteele, Jenny Jeyarajah, Vipul Jairath, Mark T Osterman, and Adam S Cheifetz. 2021. “Higher Postinduction Infliximab Concentrations Are Associated With Improved Clinical Outcomes in Fistulizing Crohn’s Disease: An ACCENT-II Post Hoc Analysis.”. The American Journal of Gastroenterology 116 (5): 1007-14.

Proactive infliximab optimisation using a pharmacokinetic dashboard versus standard of care in patients with Crohn's disease: study protocol for a randomised, controlled, multicentre, open-label study (the OPTIMIZE trial).

Publication: Journal Article

Papamichael, Konstantinos, Vipul Jairath, Guangyong Zou, Benjamin Cohen, Timothy Ritter, Bruce Sands, Corey Siegel, et al. 2022. “Proactive Infliximab Optimisation Using a Pharmacokinetic Dashboard versus Standard of Care in Patients With Crohn’s Disease: Study Protocol for a Randomised, Controlled, Multicentre, Open-Label Study (the OPTIMIZE Trial).”. BMJ Open 12 (4): e057656.

Long-term Outcomes of Patients with Crohn's Disease Treated with Risankizumab.

Publication: Journal Article

Geeganage, Grace, Ajay Gade, Alessandra Saraga, Tina Deyhim, Samantha Zullow, Loren G Rabinowitz, Adam S Cheifetz, Laurie B Grossberg, and Konstantinos Papamichael. 2025. “Long-Term Outcomes of Patients With Crohn’s Disease Treated With Risankizumab.”. Inflammatory Bowel Diseases.

Gender Equity in Gastroenterology: Perspectives From the AGA Women's Committee on Current Frameworks and Future Directions.

Publication: Journal Article

Rabinowitz, Loren G, Kira Newman, Elisa Boden, Blaire Burman, Asma Khapra, Aimee L Lucas, and AGA Women’s Committee. 2025. “Gender Equity in Gastroenterology: Perspectives From the AGA Women’s Committee on Current Frameworks and Future Directions.”. Gastroenterology 169 (2): 195-99.

Alessandra Saraga, M.D.

Person: Postdoctoral Research Fellow

Alessandra Saraga, MD is a Postdoctoral Research Fellow in Gastroenterology at Beth Israel Deaconess Medical Center. She graduated from San Raffaele University in Milan, Italy, in 2022 and has been a postdoctoral fellow at BIDMC since 2024. Dr. Saraga is pursuing internal medicine residency training...

Maria Serena Longhi, M.D., Ph.D.

Person: Associate Professor of Anaesthesia, Harvard Medical School

Dr. Longhi received her medical degree and her specialist training in Infectious Diseases at the University of Verona (Italy). She obtained a PhD degree and received postdoctoral training at King's College London, United Kingdom, where she also held Clinical Lecturer and Senior Lecturer appointments...

News and Archives

Page

Davide De Marco, M.D.

Person: Inflammatory Bowel Disease Fellow

Born and raised in Montreal, Davide attended McGill Medical School where he graduated in 2020. He then went on to complete internal medicine and gastroenterology and hepatology residency at McGill in 2025. He is currently enrolled in the Beth Israel Deaconess Medical Center Advanced Inflammatory...